TOWER SEMICONDUCTOR LTD. | |||
Date: February 29, 2024 |
By:
|
/s/ Nati Somekh | |
Name: | Nati Somekh | ||
Title: | Corporate Secretary |
Page | |
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM (PCAOB ID 1197) | F-2 - F-3 |
F-4 | |
F-5 | |
F-6 | |
F-7 | |
F-8 - F-9 | |
F-10 - F-52 |
• | We obtained the taxable income allocation used in calculating the income tax provision and tested that the taxable income allocation between Israel and corporate operations and the other subsidiaries is appropriate based on the specified services and margins determined in the Company's transfer pricing studies. |
• | We tested the effectiveness of controls over the Company’s process to allocate its taxable income between the different subsidiaries based on the Company's transfer pricing studies. |
• | We read and evaluated management’s documentation, including information obtained by management from external tax specialists that detailed the basis of the uncertain tax positions. |
• | With the assistance of our income tax specialists, we evaluated: |
• | The appropriateness of the transfer pricing analysis, including the transfer pricing methods and profit level indicators and ranges provided within the transfer pricing studies conducted by the Company’s external tax specialists. |
• | The appropriateness of the transfer pricing methodology implemented by management as provided in the transfer pricing studies. |
• | The relevant facts by reading the Company’s correspondence with the relevant tax authorities and any third-party advice obtained by the Company. | |
• | The Company’s measurement of uncertain tax positions related to transfer pricing based on our knowledge of international and local income tax laws, as well as historical settlement activity from income tax authorities. |
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
|
CONSOLIDATED BALANCE SHEETS
|
(dollars and shares in thousands)
|
As of
|
||||||||
December 31,
|
||||||||
2023
|
2022
|
|||||||
ASSETS
|
||||||||
CURRENT ASSETS
|
||||||||
Cash and cash equivalents
|
$
|
|
$
|
|
||||
Short-term deposits
|
|
|
||||||
Marketable securities (*)
|
|
|
||||||
Trade accounts receivable
|
|
|
||||||
Inventories
|
|
|
||||||
Other current assets
|
|
|
||||||
Total current assets
|
|
|
||||||
LONG-TERM INVESTMENTS
|
|
|
||||||
PROPERTY AND EQUIPMENT, NET
|
|
|
||||||
INTANGIBLE ASSETS, NET
|
|
|
||||||
GOODWILL
|
|
|
||||||
DEFERRED TAX AND OTHER LONG-TERM ASSETS, NET
|
|
|
||||||
TOTAL ASSETS
|
$
|
|
$
|
|
||||
LIABILITIES AND SHAREHOLDERS' EQUITY
|
||||||||
CURRENT LIABILITIES
|
||||||||
Current maturities of long-term debt
|
$
|
|
$
|
|
||||
Trade accounts payable
|
|
|
||||||
Deferred revenue and customers' advances
|
|
|
||||||
Employee related liabilities
|
|
|
||||||
Other current liabilities
|
|
|
||||||
Total current liabilities
|
|
|
||||||
LONG-TERM DEBT
|
|
|
||||||
LONG-TERM CUSTOMERS' ADVANCES
|
|
|
||||||
EMPLOYEE RELATED LIABILITIES
|
|
|
||||||
DEFERRED TAX AND OTHER LONG-TERM LIABILITIES
|
|
|
||||||
TOTAL LIABILITIES
|
|
|
||||||
Ordinary shares of NIS
|
|
|
||||||
|
||||||||
|
||||||||
|
||||||||
Additional paid-in capital
|
|
|
||||||
Cumulative stock based compensation
|
|
|
||||||
Accumulated other comprehensive loss
|
(
|
)
|
(
|
)
|
||||
Retained earnings (accumulated deficit)
|
|
(
|
)
|
|||||
|
|
|||||||
Treasury stock, at cost -
|
(
|
)
|
(
|
)
|
||||
THE COMPANY'S SHAREHOLDERS' EQUITY
|
|
|
||||||
Non-controlling interest
|
(
|
)
|
(
|
)
|
||||
TOTAL SHAREHOLDERS' EQUITY
|
|
|
||||||
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY
|
$
|
|
$
|
|
F - 4
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
|
CONSOLIDATED STATEMENTS OF OPERATIONS
|
(dollars and shares in thousands, except per share data)
|
Year ended December 31,
|
||||||||||||
2023
|
2022
|
2021
|
||||||||||
REVENUES
|
$
|
|
$
|
|
$
|
|
||||||
COST OF REVENUES
|
|
|
|
|||||||||
GROSS PROFIT
|
|
|
|
|||||||||
OPERATING COSTS AND EXPENSES:
|
||||||||||||
Research and development
|
|
|
|
|||||||||
Marketing, general and administrative
|
|
|
|
|||||||||
Restructuring gain from sale of machinery and equipment, net
|
(
|
)
|
(
|
)
|
|
|||||||
Restructuring expense
|
|
|
|
|||||||||
Merger-contract termination fee, net
|
(
|
)
|
|
|
||||||||
(
|
)
|
|
|
|||||||||
OPERATING PROFIT
|
|
|
|
|||||||||
FINANCING INCOME (EXPENSE), NET
|
|
(
|
)
|
(
|
)
|
|||||||
OTHER INCOME (EXPENSE), NET
|
|
(
|
)
|
|
||||||||
PROFIT BEFORE INCOME TAX
|
|
|
|
|||||||||
INCOME TAX EXPENSE, NET
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
NET PROFIT
|
|
|
|
|||||||||
Net income attributable to non-controlling interest
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
NET PROFIT ATTRIBUTABLE TO THE COMPANY
|
$
|
|
$
|
|
$
|
|
||||||
BASIC EARNINGS PER SHARE
|
||||||||||||
Earnings per share
|
$
|
|
$
|
|
$
|
|
||||||
Weighted average number of shares
|
|
|
|
|||||||||
DILUTED EARNINGS PER ORDINARY SHARE:
|
||||||||||||
Earnings per share
|
$
|
|
$
|
|
$
|
|
||||||
Net profit used for diluted earnings per share
|
|
$
|
|
$
|
|
|||||||
Weighted average number of ordinary shares outstanding
|
||||||||||||
used for diluted earnings per share
|
|
|
|
See notes to consolidated financial statements.
|
F - 5
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
|
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
|
(dollars in thousands)
|
Year ended December 31,
|
||||||||||||
2023
|
2022
|
2021
|
||||||||||
Net profit
|
$
|
|
$
|
|
$
|
|
||||||
Other comprehensive income, net of tax:
|
||||||||||||
Foreign currency translation adjustment
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Change in employees plan assets and benefit obligations, net of taxes
|
(
|
)
|
(
|
)
|
|
|||||||
Unrealized gain (loss) on derivatives and marketable securities
|
|
(
|
)
|
(
|
)
|
|||||||
Comprehensive income
|
|
|
|
|||||||||
Comprehensive loss attributable to non-controlling interest
|
|
|
|
|||||||||
Comprehensive income attributable to the Company
|
$
|
|
$
|
|
$
|
|
See notes to consolidated financial statements.
|
F - 6
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
|
CONSOLIDATED STATEMENT OF CHANGES IN SHAREHOLDERS' EQUITY
|
(dollars and share data in thousands)
|
THE COMPANY'S SHAREHOLDERS' EQUITY
|
||||||||||||||||||||||||||||||||||||||||||||
Accumulated
|
Foreign
|
Retained
|
||||||||||||||||||||||||||||||||||||||||||
Ordinary
|
Ordinary
|
Additional
|
other
|
currency
|
earnings
|
Non
|
||||||||||||||||||||||||||||||||||||||
shares
|
shares
|
paid-in
|
Unearned
|
comprehensive
|
translation
|
(accumulated
|
Treasury
|
Comprehensive
|
controlling
|
|||||||||||||||||||||||||||||||||||
issued
|
amount
|
capital
|
compensation
|
income (loss)
|
adjustments
|
deficit)
|
stock
|
income
|
interest
|
Total
|
||||||||||||||||||||||||||||||||||
BALANCE AS OF JANUARY 1, 2021
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
||||||||||||||||||||
Changes during the year ended December 31, 2021:
|
||||||||||||||||||||||||||||||||||||||||||||
Exercise of options and RSUs
|
|
|
(
|
)
|
|
|||||||||||||||||||||||||||||||||||||||
Employee stock-based compensation
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Other comprehensive income:
|
||||||||||||||||||||||||||||||||||||||||||||
Profit
|
|
$
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Foreign currency translation adjustments
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||||||||||||||||||||||||||
Change in employees plan assets and benefit obligations
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||
Unrealized loss on derivatives and marketable securities
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||||||||||||||||||||||||||||
Comprehensive income
|
$
|
|
||||||||||||||||||||||||||||||||||||||||||
BALANCE AS OF DECEMBER 31, 2021
|
|
|
|
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
|
|||||||||||||||||||||||||||||
Changes during the year ended December 31, 2022:
|
||||||||||||||||||||||||||||||||||||||||||||
Proceeds from an investment in a subsidiary
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Exercise of options and RSUs
|
|
|
(
|
)
|
|
|||||||||||||||||||||||||||||||||||||||
Employee stock-based compensation
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Other comprehensive income:
|
||||||||||||||||||||||||||||||||||||||||||||
Profit
|
|
$
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Foreign currency translation adjustments
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||||||||||||||||||||||||||
Change in employees plan assets and benefit obligations
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||||||||||||||||||||||||||||
Unrealized loss on derivatives and marketable securities
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||||||||||||||||||||||||||||
Comprehensive income
|
$
|
|
||||||||||||||||||||||||||||||||||||||||||
BALANCE AS OF DECEMBER 31, 2022
|
|
|
|
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
|
|||||||||||||||||||||||||||||
Changes during the year ended December 31, 2023:
|
||||||||||||||||||||||||||||||||||||||||||||
Proceeds from an investment in a subsidiary
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Exercise of options and RSUs
|
|
|
(
|
)
|
-
|
|||||||||||||||||||||||||||||||||||||||
Employee stock-based compensation
|
|
|
||||||||||||||||||||||||||||||||||||||||||
Other comprehensive income:
|
||||||||||||||||||||||||||||||||||||||||||||
Profit
|
|
$
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
Foreign currency translation adjustments
|
(
|
)
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||||||||||||||||||||||||||
Change in employees plan assets and benefit obligations
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||||||||||||||||||||||||||||||||||
Unrealized gain on derivatives and marketable securities
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||
Comprehensive income
|
$
|
|
||||||||||||||||||||||||||||||||||||||||||
BALANCE AS OF DECEMBER 31, 2023
|
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
||||||||||||||||||||||
OUTSTANDING SHARES, NET OF TREASURY STOCK
AS OF DECEMBER 31, 2023 |
|
See notes to consolidated financial statements.
|
F - 7
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
|
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
(dollars in thousands)
|
Year ended December 31,
|
||||||||||||
2023
|
2022
|
2021
|
||||||||||
CASH FLOWS - OPERATING ACTIVITIES
|
||||||||||||
Net profit for the period
|
$
|
|
$
|
|
$
|
|
||||||
Adjustments to reconcile net profit for the period
|
||||||||||||
to net cash provided by operating activities:
|
||||||||||||
Income and expense items not involving cash flows:
|
||||||||||||
Depreciation and amortization
|
|
|
|
|||||||||
Effect of exchange rate differences and fair value adjustment
|
(
|
)
|
|
|
||||||||
Other expense (income), net
|
(
|
)
|
|
(
|
)
|
|||||||
Changes in assets and liabilities:
|
||||||||||||
Trade accounts receivable
|
(
|
)
|
(
|
)
|
|
|||||||
Other current assets
|
(
|
)
|
|
(
|
)
|
|||||||
Inventories
|
|
(
|
)
|
(
|
)
|
|||||||
Trade accounts payable
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Deferred revenue and customers' advances
|
(
|
)
|
(
|
)
|
|
|||||||
Employee related liabilities and other current liabilities
|
(
|
)
|
|
|
||||||||
Long-term employee related liabilities
|
(
|
)
|
|
(
|
)
|
|||||||
Deferred tax, net and other long-term liabilities
|
|
|
(
|
)
|
||||||||
Net cash provided by operating activities
|
|
|
|
|||||||||
CASH FLOWS - INVESTING ACTIVITIES
|
||||||||||||
Investments in property and equipment, net
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Proceeds related to sale and disposal of property and equipment
|
|
|
|
|||||||||
Proceeds from investment realization
|
|
|
|
|||||||||
Investments in other assets
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Deposits and marketable securities, net
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Net cash used in investing activities
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
CASH FLOWS - FINANCING ACTIVITIES
|
||||||||||||
Proceeds from an investment in a subsidiary
|
|
|
|
|||||||||
Exercise of options, net
|
|
|
|
|||||||||
Proceeds from loans
|
|
|
|
|||||||||
Loans repayment
|
|
|
(
|
)
|
||||||||
Principal payments on account of capital lease obligation
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Debentures repayment
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Net cash used in financing activities
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
EFFECT OF FOREIGN CURRENCY EXCHANGE RATE CHANGE
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS
|
(
|
)
|
|
(
|
)
|
|||||||
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD
|
|
|
|
|||||||||
CASH AND CASH EQUIVALENTS - END OF PERIOD
|
$
|
|
$
|
|
$
|
|
See notes to consolidated financial statements.
|
F - 8
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
|
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
(dollars in thousands)
|
Year ended December 31,
|
||||||||||||
2023
|
2022
|
2021
|
||||||||||
NON-CASH ACTIVITIES:
|
||||||||||||
Investments in property and equipment
|
$
|
|
$
|
|
$
|
$
|
||||||
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
|
||||||||||||
Cash received during the period from interest
|
$
|
|
$
|
|
$
|
$
|
||||||
Cash paid during the period for interest
|
$
|
|
$
|
|
$
|
$
|
||||||
Cash paid for income taxes, net during the period
|
$
|
|
$
|
|
$
|
$
|
See notes to consolidated financial statements.
|
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
F - 10
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
F - 11
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
NOTE 2: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)
F - 12
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
• |
Buildings and building improvements, including facility infrastructure:
|
• |
Machinery and equipment, software and hardware:
|
F - 13
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
F - 14
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
F - 15
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
F - 16
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
F - 17
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
F - 18
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
F - 19
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
Details
|
2023
|
2022
|
||||||
Raw materials
|
$
|
|
$
|
|
||||
Work in process
|
|
|
||||||
Finished goods
|
|
|
||||||
$
|
|
$
|
|
F - 20
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
Details
|
2023
|
2022
|
||||||
Direct and indirect tax receivables
|
$
|
|
$
|
|
||||
Prepaid expenses
|
|
|
||||||
Receivables from hedging transactions - see Notes 10, 12A and 12D
|
|
|
||||||
Other receivables
|
|
|
||||||
$
|
|
$
|
|
Details
|
2023
|
2022
|
||||||
Investments in privately held companies
|
$
|
|
$
|
|
||||
Severance-pay funds
|
|
|
||||||
$
|
|
$
|
|
Details
|
2023
|
2022
|
||||||
Original cost: (*)
|
||||||||
Land and buildings, including facility infrastructure
|
$
|
|
$
|
|
||||
Machinery and equipment
|
|
|
||||||
|
|
|||||||
Accumulated depreciation:
|
||||||||
Buildings, including facility infrastructure
|
(
|
)
|
(
|
)
|
||||
Machinery and equipment
|
(
|
)
|
(
|
)
|
||||
(
|
)
|
(
|
)
|
|||||
$
|
|
$
|
|
F - 21
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
Details
|
Useful life
(years)
|
Cost
|
Accumulated Amortization
|
Net
|
||||||||||||
Facilities’ lease
|
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||
Technologies
|
|
|
(
|
)
|
|
|||||||||||
Customer relationships
|
|
|
(
|
)
|
|
|||||||||||
Total identifiable intangible assets
|
$
|
|
$
|
(
|
)
|
$
|
|
Details
|
Useful life
(years)
|
Cost
|
Accumulated Amortization
|
Net
|
||||||||||||
Facilities’ lease
|
|
$
|
|
$
|
(
|
)
|
$
|
|
||||||||
Technologies
|
|
|
(
|
)
|
|
|||||||||||
Customer relationships
|
|
|
(
|
)
|
|
|||||||||||
Total identifiable intangible assets
|
$
|
|
$
|
(
|
)
|
$
|
|
Details
|
2023
|
2022
|
||||||
Long-term prepaid expenses
|
$
|
|
$
|
|
||||
ROU - assets under operating leases
|
|
|
||||||
Prepaid long-term land lease, net
|
|
|
||||||
Deferred tax asset (see Note 19)
|
|
|
||||||
$
|
|
$
|
|
Details
|
2023
|
2022
|
||||||
Tax payables
|
$
|
|
$
|
|
||||
Hedging transactions related payables
|
|
|
||||||
Interest payable on debt
|
|
|
||||||
Proceeds on account of machinery and equipment to be sold in relation to restructuring (see also note 14B2)
|
|
|
||||||
Others
|
|
|
||||||
$
|
|
$
|
|
F - 22
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
Details
|
2023
|
2022
|
||||||
Long-term JPY loans - principal amount - see Notes 11B and 11C below
|
$
|
|
$
|
|
||||
- see Note 11D below
|
|
|
||||||
Operating leases - see Note 11E below
|
|
|
||||||
Less - current maturities
|
(
|
)
|
(
|
)
|
||||
$
|
|
$
|
|
Details
|
Interest
Rate
|
2024
|
2025
|
2026
|
2027
|
Total
|
||||||||||||||||||
Long-term 2021 JPY loan
|
|
%
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||||||
Long-term 2023 JPY loan
|
|
%
|
|
|
|
|
|
|||||||||||||||||
Total long-term JPY loans
|
$
|
|
$
|
|
$
|
|
$
|
|
$
|
|
F - 23
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
Fiscal Year
|
Amount ($)
|
|||
2024
|
$
|
|
||
2025
|
|
|||
2026
|
|
|||
2027
|
|
|||
2028
|
|
|||
2029 and on
|
|
|||
Total
|
|
|||
Less - imputed interest
|
(
|
)
|
||
Total
|
$
|
|
F - 24
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
Details
|
Classification in the Consolidated Balance Sheets
|
December 31, 2023
|
December 31, 2022
|
||||||
ROU - assets under operating leases
|
|
$
|
|
$
|
|
||||
Lease liabilities:
|
|||||||||
Current operating lease liabilities
|
|
$
|
|
$
|
|
||||
Long-term operating lease liabilities
|
|
|
|
||||||
Total operating lease liabilities
|
$
|
|
$
|
|
|||||
Weighted average remaining lease term (years)
|
|
|
|||||||
Weighted average discount rate
|
|
%
|
|
%
|
Fiscal Year
|
Amount ($)
|
|||
2024
|
$
|
|
||
2025
|
|
|||
2026
|
|
|||
2027
|
|
|||
Total
|
|
|||
Less - imputed interest
|
(
|
)
|
||
Total
|
$
|
|
F - 25
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
F - 26
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
F - 27
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
F - 28
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
Details
|
December 31, 2023
|
Quoted prices in active market
(Level 1)
|
Significant other observable inputs
(Level 2)
|
Significant unobservable inputs
(Level 3)
|
||||||||||||
Privately held companies
|
|
|
|
|
||||||||||||
Marketable securities held for sale
|
|
|
|
|
||||||||||||
Foreign exchange forward and cylinders - net asset position
|
|
|
|
|
||||||||||||
$
|
|
$
|
|
$
|
|
$
|
|
Details
|
December 31, 2022
|
Quoted prices in active market
(Level 1)
|
Significant other observable inputs
(Level 2)
|
Significant unobservable inputs
(Level 3)
|
||||||||||||
Cross-currency swap - net asset position
|
$
|
|
$
|
|
$
|
|
$
|
|
||||||||
Privately held companies
|
|
|
|
|
||||||||||||
Marketable securities held for sale
|
|
|
|
|
||||||||||||
Foreign exchange forward and cylinders - net liability position
|
(
|
)
|
|
(
|
)
|
|
||||||||||
$
|
|
$
|
|
$
|
|
$
|
|
F - 29
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
Details
|
Amortized
Cost (*)
|
Gross unrealized gains
|
Gross unrealized losses
|
Estimated fair value
|
||||||||||||
Corporate bonds
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
Government bonds
|
|
|
(
|
)
|
|
|||||||||||
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
The scheduled maturities of available-for-sale marketable securities as of December 31, 2023, were as follows:
Details
|
Amortized Cost
|
Estimated fair value
|
||||||
Due within one year
|
$
|
|
$
|
|
||||
Due within 2-5 years
|
|
|
||||||
Due after 5 years
|
|
|
||||||
$
|
|
$
|
|
Details
|
Amortized
Cost (*)
|
Gross unrealized gains
|
Gross unrealized losses
|
Estimated fair
value
|
||||||||||||
Corporate bonds
|
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||||
Government bonds
|
|
|
(
|
)
|
|
|||||||||||
Municipal bonds
|
|
|
(
|
)
|
|
|||||||||||
$
|
|
$
|
|
$
|
(
|
)
|
$
|
|
F - 30
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
Details
|
Amortized Cost
|
Estimated fair value
|
||||||
Due within one year
|
$
|
|
$
|
|
||||
Due within 2-5 years
|
|
|
||||||
Due after 5 years
|
|
|
||||||
$
|
|
$
|
|
December 31, 2023
|
||||||||||||||||||||||||
Investments with continuous unrealized losses for less than twelve months
|
Investments with continuous unrealized losses for twelve months or more
|
Total investments with continuous unrealized losses
|
||||||||||||||||||||||
Details
|
Fair value
|
Unrealized losses
|
Fair value
|
Unrealized losses
|
Fair value
|
Unrealized losses
|
||||||||||||||||||
Corporate bonds
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
|||||||||
Government bonds
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||||
Total
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
December 31, 2022 | ||||||||||||||||||||||||
Investments with continuous unrealized losses for less than twelve months
|
Investments with continuous unrealized losses for twelve months or more
|
Total investments with continuous unrealized losses
|
||||||||||||||||||||||
Details
|
Fair value
|
Unrealized losses
|
Fair value
|
Unrealized losses
|
Fair value
|
Unrealized losses
|
||||||||||||||||||
Corporate bonds
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
|||||||||
Government bonds
|
|
(
|
)
|
|
(
|
)
|
|
(
|
)
|
|||||||||||||||
Municipal bonds
|
|
|
|
(
|
)
|
|
(
|
)
|
||||||||||||||||
Total
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
$
|
|
$
|
(
|
)
|
F - 31
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
F - 32
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
Details
|
2023
|
2022
|
2021
|
|||||||||
Net periodic benefit cost:
|
||||||||||||
Service cost
|
$
|
|
$
|
|
$
|
|
||||||
Interest cost
|
|
|
|
|||||||||
Amortization of prior service costs
|
|
|
|
|||||||||
Amortization of net gain |
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Total net periodic benefit cost
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
|||
Other changes in plan assets and benefits obligations recognized in other comprehensive income:
|
||||||||||||
Prior service cost for the period
|
$
|
|
$
|
|
$
|
|
||||||
Net gain for the period
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Amortization of prior service costs
|
|
|
|
|||||||||
Amortization of net gain
|
|
|
|
|||||||||
Total recognized in other comprehensive income
|
$
|
|
$
|
(
|
)
|
$
|
|
|||||
Total recognized in net periodic benefit cost and other comprehensive income |
$
|
(
|
)
|
$
|
(
|
)
|
$
|
|
||||
Weighted average assumptions used:
|
||||||||||||
Discount rate
|
|
%
|
|
%
|
|
%
|
||||||
Expected return on plan assets
|
|
|
|
|||||||||
Rate of compensation increases
|
|
|
|
|||||||||
Assumed health care cost trend rates:
|
||||||||||||
Health care cost trend rate assumed for current year (pre-65/post-65 Medicare Advantage)
|
|
%
|
|
%
|
|
%
|
||||||
Health care cost trend rate assumed for current year (pre-65/post-65 Non-Medicare Advantage)
|
|
%
|
|
%
|
|
%
|
||||||
Ultimate rate (pre-65/post-65)
|
|
%
|
|
%
|
|
%
|
||||||
Year the ultimate rate is reached (pre-65/post-65) |
|
|
|
|||||||||
Measurement date
|
|
|
|
F - 33
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
Details
|
2023
|
2022
|
2021
|
|||||||||
Change in medical plan related benefit obligation:
|
||||||||||||
Medical plan related benefit obligation at beginning of period
|
$
|
|
$
|
|
$
|
|
||||||
Service cost
|
|
|
|
|||||||||
Interest cost
|
|
|
|
|||||||||
Benefits paid
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Change in medical plan provisions
|
|
|
|
|||||||||
Actuarial gain, net |
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Benefit medical plan related obligation end of period
|
$
|
|
$
|
|
$
|
|
||||||
Change in plan assets:
|
||||||||||||
Fair value of plan assets at beginning of period
|
$
|
|
$
|
|
$
|
|
||||||
Employer contribution
|
|
|
|
|||||||||
Benefits paid
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Fair value of plan assets at end of period
|
$
|
|
$
|
|
$
|
|
||||||
Medical plan related net funding
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
F - 34
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
Details
|
2023
|
2022
|
2021
|
|||||||||
Amounts recognized in statement of financial position:
|
||||||||||||
Current liabilities
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
|||
Non-current liabilities
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Net amount recognized
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
|||
Weighted average assumptions used:
|
||||||||||||
Discount rate
|
|
%
|
|
%
|
|
%
|
||||||
Rate of compensation increases
|
|
|
|
|||||||||
Assumed health care cost trend rates:
|
||||||||||||
Health care cost trend rate assumed for next year (pre-65/post-65 Medicare Advantage)
|
|
%
|
|
%
|
|
%
|
||||||
Health care cost trend rate assumed for next year (pre-65/post-65 Non-Medicare Advantage)
|
|
%
|
|
%
|
|
%
|
||||||
Ultimate rate (pre-65/post-65 Medicare Advantage)
|
|
%
|
|
%
|
|
%
|
||||||
Ultimate rate (pre-65/post-65 Non-Medicare Advantage)
|
|
%
|
|
%
|
|
%
|
||||||
Year the ultimate rate is reached (pre-65/post-65 Medicare Advantage)
|
|
|
|
|||||||||
Year the ultimate rate is reached (pre-65/post-65 Non-Medicare Advantage) |
|
|
|
Fiscal Year
|
Other Benefits
|
|||
2024
|
$
|
|
||
2025
|
|
|||
2026
|
|
|||
2027
|
|
|||
2028
|
|
|||
2029 - 2033
|
$
|
|
F - 35
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
Details
|
2023
|
2022
|
2021
|
|||||||||
Net periodic benefit cost:
|
||||||||||||
Interest cost
|
$
|
|
$
|
|
$
|
|
||||||
Expected return on plan assets
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Expected administrative expenses
|
|
|
|
|||||||||
Amortization of prior service costs
|
|
|
|
|||||||||
Amortization of net loss
|
|
|
|
|||||||||
Total net periodic benefit cost
|
$
|
|
$
|
|
$
|
(
|
)
|
|||||
Other changes in plan assets and benefits obligations recognized in other comprehensive income:
|
||||||||||||
Prior service cost for the period
|
$
|
|
$
|
|
$
|
|
||||||
Net loss (gain) for the period
|
|
|
(
|
)
|
||||||||
Amortization of prior service costs
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Amortization of net gain
|
(
|
)
|
|
(
|
)
|
|||||||
Total recognized loss (gain) in other comprehensive income = |
$
|
|
$
|
|
$
|
(
|
)
|
|||||
Total recognized in net periodic benefit cost (gain) and other comprehensive income |
$
|
|
$
|
|
$
|
(
|
)
|
|||||
Weighted average assumptions used:
|
||||||||||||
Discount rate
|
|
%
|
|
%
|
|
%
|
||||||
Expected return on plan assets
|
|
%
|
|
%
|
|
%
|
||||||
Rate of compensation increases
|
|
|
|
F - 36
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
Details
|
2023
|
2022
|
2021
|
|||||||||
Change in benefit obligation:
|
||||||||||||
Benefit obligation at beginning of period
|
$
|
|
$
|
|
$
|
|
||||||
Interest cost
|
|
|
|
|||||||||
Benefits paid
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Change in plan provisions
|
|
|
|
|||||||||
Actuarial loss (gain)
|
|
(
|
)
|
(
|
)
|
|||||||
Benefit obligation end of period
|
$
|
|
$
|
|
$
|
|
||||||
Change in plan assets:
|
||||||||||||
Fair value of plan assets at beginning of period
|
$
|
|
$
|
|
$
|
|
||||||
Actual return on plan assets
|
|
(
|
)
|
|
||||||||
Employer contribution
|
|
|
|
|||||||||
Expenses paid
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Benefits paid
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Fair value of plan assets at end of period
|
$
|
|
$
|
|
$
|
|
||||||
Funded Status
|
$
|
|
$
|
|
$
|
|
||||||
Amounts recognized in statement of financial position:
|
||||||||||||
Non-current assets
|
$
|
|
$
|
|
$
|
|
||||||
Non-current liabilities
|
|
|
|
|||||||||
Net amount recognized
|
$
|
|
$
|
|
$
|
|
||||||
Weighted average assumptions used:
|
||||||||||||
Discount rate
|
|
%
|
|
%
|
|
%
|
||||||
Rate of compensation increases
|
|
|
|
F - 37
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
Fiscal Year
|
Other Benefits
|
|||
2024
|
$
|
|
||
2025
|
|
|||
2026
|
|
|||
2027
|
|
|||
2028
|
|
|||
2029 - 2033
|
$
|
|
Details
|
Level 1
|
Level 2
|
Level 3
|
|||||||||
Investments in commingled funds
|
$
|
|
$
|
|
$
|
|
||||||
Total plan assets at fair value
|
$
|
|
$
|
|
$
|
|
Details
|
Level 1
|
Level 2
|
Level 3
|
|||||||||
Investments in commingled funds
|
$
|
|
$
|
|
$
|
|
||||||
Total plan assets at fair value
|
$
|
|
$
|
|
$
|
|
Asset Category
|
December 31, 2023
|
Target allocation 2024
|
||||||
Equity securities
|
|
%
|
|
%
|
||||
Debt securities
|
|
%
|
|
%
|
||||
Total
|
|
%
|
|
%
|
F - 38
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
F - 39
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
NOTE 14: COMMITMENTS AND CONTINGENCIES (continued)
Details
|
Asset disposal accrual
|
Other Restructuring costs accrual
|
||||||
Accrued balance as of January 1, 2022
|
$
|
|
$
|
|
||||
Expenses accrued
|
|
|
||||||
Accruals related to assets
|
|
|
||||||
Cash payments
|
(
|
)
|
(
|
)
|
||||
Accrued balance as of December 31, 2022
|
$
|
|
$
|
|
||||
Expenses accrued
|
|
|
||||||
Accruals related to assets
|
(
|
)
|
(
|
)
|
||||
Cash payments
|
(
|
)
|
(
|
)
|
||||
Accrued balance as of December 31, 2023
|
$
|
|
$
|
|
F - 40
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
NOTE 14: COMMITMENTS AND CONTINGENCIES (continued)
NOTE 15: SHAREHOLDERS’ EQUITY
F - 41
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
NOTE 15: SHAREHOLDERS’ EQUITY (continued)
F - 42
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
NOTE 15: SHAREHOLDERS’ EQUITY (continued)
F - 43
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
NOTE 15: SHAREHOLDERS’ EQUITY (continued)
2023
|
2022
|
2021
|
||||||||||||||||||||||
Details
|
Number of RSUs
|
Weighted average fair value
|
Number of RSUs
|
Weighted average fair value
|
Number of RSUs
|
Weighted average fair value
|
||||||||||||||||||
Outstanding as of beginning of year
|
|
$
|
|
|
$
|
|
|
$
|
|
|||||||||||||||
Granted
|
|
$
|
|
|
$
|
|
|
$
|
|
|||||||||||||||
Converted
|
(
|
)
|
$
|
|
(
|
)
|
$
|
|
(
|
)
|
$
|
|
||||||||||||
Forfeited
|
(
|
)
|
$
|
|
(
|
)
|
$
|
|
(
|
)
|
$
|
|
||||||||||||
Outstanding as of end of year (*)
|
|
$
|
|
|
$
|
|
|
$
|
|
Details for the year ended December 31
|
2023
|
2022
|
2021
|
|||||||||
The intrinsic value of converted RSUs
|
$
|
|
$
|
|
$
|
|
||||||
The original fair value of converted RSUs
|
$
|
|
$
|
|
$
|
|
Details
|
2023
|
2022
|
2021
|
|||||||||
Cost of goods
|
$
|
|
$
|
|
$
|
|
||||||
Research and development, net
|
|
|
|
|||||||||
Marketing, general and administrative
|
|
|
|
|||||||||
Total stock-based compensation expense
|
$
|
|
$
|
|
$
|
|
F - 44
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
Details
|
2023
|
2022
|
2021
|
|||||||||
USA
|
|
%
|
|
%
|
|
%
|
||||||
Japan
|
|
|
|
|||||||||
Asia (other than Japan)
|
|
|
|
|||||||||
Europe
|
|
|
|
|||||||||
Total
|
|
%
|
|
%
|
|
%
|
Details
|
2023
|
2022
|
||||||
Israel
|
$
|
|
$
|
|
||||
United States
|
|
|
||||||
Europe
|
|
|
||||||
Japan
|
|
|
||||||
$
|
|
$
|
|
F - 45
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
Details
|
2023
|
2022
|
2021
|
|||||||||
Customer A
|
|
%
|
|
%
|
|
%
|
||||||
Customer B
|
|
|
|
|||||||||
Other customers *
|
|
|
|
* |
|
Details
|
2023
|
2022
|
2021
|
|||||||||
Interest expense
|
$
|
(
|
)
|
$
|
(
|
)
|
$
|
(
|
)
|
|||
Interest income
|
|
|
|
|||||||||
Series G Debentures amortization, exchange rate and hedging transactions related results
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Exchange rate and hedging transactions related results
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Marketable securities fair value adjustments
|
|
(
|
)
|
|
||||||||
Bank fees and others
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
$
|
|
$
|
(
|
)
|
$
|
(
|
)
|
F - 46
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
Details
|
2023
|
2022
|
|||||||
Long-term investment
|
Equity investment in a limited partnership
|
$
|
|
$
|
|
Details
|
Description of the transactions
|
2023
|
2022
|
2021
|
||||||||||
General and administrative expense
|
Directors’ fees and reimbursement to directors
|
$
|
|
$
|
|
$
|
|
F - 47
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
Details
|
2023
|
2022
|
2021
|
|||||||||
Current tax expense:
|
||||||||||||
Foreign
|
$
|
|
$
|
|
$
|
|
||||||
Deferred tax expense (benefit):
|
||||||||||||
Local
|
|
|
|
|||||||||
Foreign
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Income tax expense, net
|
$
|
|
$
|
|
$
|
|
Details
|
2023
|
2022
|
2021
|
|||||||||
Profit before taxes:
|
||||||||||||
Local
|
$
|
|
$
|
|
$
|
|
||||||
Foreign
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Total profit before taxes
|
$
|
|
$
|
|
$
|
|
F - 48
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
Details
|
2023
|
2022
|
||||||
Deferred tax asset and liability - long-term:
|
||||||||
Deferred tax assets:
|
||||||||
Net operating loss carryforward
|
$
|
|
$
|
|
||||
Employees compensation
|
|
|
||||||
Accruals and allowances
|
|
|
||||||
Research and development credit
|
|
|
||||||
Research and development - Section 174
|
|
|
||||||
Lease liabilities
|
|
|
||||||
Others
|
|
|
||||||
|
|
|||||||
Valuation allowance, see Note 19F below
|
(
|
)
|
(
|
)
|
||||
Deferred tax assets
|
$
|
|
$
|
|
||||
Deferred tax liabilities - long-term:
|
||||||||
Depreciation and amortization
|
$
|
(
|
)
|
$
|
(
|
)
|
||
ROU - assets under operating leases
|
(
|
)
|
(
|
)
|
||||
Others
|
(
|
)
|
|
|||||
Deferred tax liabilities
|
$
|
(
|
)
|
$
|
(
|
)
|
||
Presented in long term deferred tax assets
|
$
|
|
$
|
|
||||
Presented in long term deferred tax liabilities
|
$
|
(
|
)
|
$
|
(
|
)
|
F - 49
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
Details
|
Unrecognized tax benefits
|
|||
Balance as of January 1, 2023
|
$
|
|
||
Additions for tax positions of current year
|
|
|||
Reduction due to statute of limitations of prior years
|
|
|||
Balance as of December 31, 2023
|
$
|
|
Details
|
Unrecognized tax benefits
|
|||
Balance as of January 1, 2022
|
$
|
|
||
Additions for tax positions of current year
|
|
|||
Reduction due to statute of limitations of prior years
|
|
|||
Balance as of December 31, 2022
|
$
|
|
Details
|
Unrecognized tax benefits
|
|||
Balance as of January 1, 2021
|
$
|
|
||
Additions for tax positions of current year
|
|
|||
Reduction due to statute of limitations of prior years
|
(
|
)
|
||
Balance as of December 31, 2021
|
$
|
|
Details
|
2023
|
2022
|
2021
|
|||||||||
Tax expense computed at statutory rates, see (*) below
|
$
|
|
$
|
|
$
|
|
||||||
Effect of different tax rates in different jurisdictions and Preferred Enterprise Benefit
|
(
|
)
|
(
|
)
|
(
|
)
|
||||||
Change in valuation allowance, see Note 19F below
|
|
|
|
|||||||||
Permanent differences and other, net
|
|
(
|
)
|
(
|
)
|
|||||||
Income tax expense
|
$
|
|
$
|
|
$
|
|
F - 50
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
F - 51
TOWER SEMICONDUCTOR LTD. AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
AS OF DECEMBER 31, 2023
(dollars in thousands, except per share data)
F - 52
Details
|
2023
|
2022
|
||||||
Revenues
|
100
|
%
|
100
|
%
|
||||
Cost of Revenues
|
75.2
|
72.2
|
||||||
Gross profit
|
24.8
|
27.8
|
||||||
Research and Development expense
|
5.6
|
5.0
|
||||||
Marketing, general and administrative expense
|
5.1
|
4.8
|
||||||
Restructuring gain from sale of machinery and equipment, net
|
(3.7
|
)
|
(1.2
|
)
|
||||
Restructuring expense
|
1.3
|
0.6
|
||||||
Merger-contract termination fee, net
|
(22.0
|
)
|
--
|
|||||
Operating profit
|
38.5
|
18.6
|
||||||
Financing income (expense), net
|
2.1
|
(0.8
|
)
|
|||||
Other income (expense), net
|
0.5
|
(0.4
|
)
|
|||||
Profit before income tax
|
41.1
|
17.4
|
||||||
Income tax expense, net
|
(4.6
|
)
|
(1.5
|
)
|
||||
Net profit
|
36.5
|
15.9
|
||||||
Net income attributable to non-controlling interest
|
(0.1
|
)
|
(0.1
|
)
|
||||
Net profit attributable to the company
|
36.4
|
%
|
15.8
|
%
|
Details
|
2023
|
2022
|
||||||
Revenues
|
$
|
1,422,680
|
$
|
1,677,614
|
||||
Cost of Revenues
|
1,069,161
|
1,211,306
|
||||||
Gross profit
|
353,519
|
466,308
|
||||||
Research and Development expense
|
79,808
|
83,911
|
||||||
Marketing, general and administrative expense
|
72,454
|
80,282
|
||||||
Restructuring gain from sale of machinery and equipment, net
|
(52,168
|
)
|
(20,243
|
)
|
||||
Restructuring expense
|
19,662
|
10,684
|
||||||
Merger-contract termination fee, net
|
(313,501
|
)
|
--
|
|||||
Operating profit
|
547,264
|
311,674
|
||||||
Financing income (expense), net
|
30,531
|
(12,767
|
)
|
|||||
Other income (expense), net
|
7,047
|
(6,934
|
)
|
|||||
Profit before income tax
|
584,842
|
291,973
|
||||||
Income tax expense, net
|
(65,312
|
)
|
(25,502
|
)
|
||||
Net profit
|
519,530
|
266,471
|
||||||
Net income attributable to non-controlling interest
|
(1,036
|
)
|
(1,902
|
)
|
||||
Net profit attributable to the company
|
$
|
518,494
|
$
|
264,569
|